BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.26.0//EN
X-ORIGINAL-URL:https://lifesciencescollaborative.org/
X-WR-CALNAME:Life Sciences Collaborative
X-WR-CALDESC:
X-WR-TIMEZONE:UTC
BEGIN:VTIMEZONE
TZID:UTC
X-LIC-LOCATION:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20261024T050121
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-e069ea4c9c233d36ff9c7f329bc08ff1@lifesciencescollaborative.org
DTSTART;TZID=UTC:20200303T070000
DTEND;TZID=UTC:20200303T160000
DTSTAMP:20240903T105052Z
CREATED:20240903
LAST-MODIFIED:20240903
PRIORITY:5
SEQUENCE:0
TRANSP:OPAQUE
SUMMARY:Innovators and Investors: The Journey from Entry to Exit
DESCRIPTION:Breakfast Buffet, Hot Lunch, and Free Parking are included.\nThe Life Sciences Collaborative is proud to invite you to our 7th annual conference at USciences in Philadelphia.\nAlong with a breakfast buffet, lunch, networking with peers/influencers, and free parking, our program will include:\nPhiladelphia is consistently ranked in the top 10 life sciences clusters in the country, due to our proximity to Big Pharma, excellent research institutions, and robust talent pool. Venture capital funding of Philly-based life sciences companies, while still trailing Boston, San Francisco, San Diego, and others, has grown significantly in the last several years. With our maturing eco-system, now is a great time to start or grow a life sciences company in the region.\nHowever, we realize that emerging life science companies in our region face a lot of challenges. These challenges include navigating the balance between building a business and optimizing scientific progress, sourcing and working with investors, and entering into commercialization.\nCome join the Life Sciences Collaborative for our 7th annual conference to hear from both innovators and investors on their journeys to building sustainable and profitable life sciences businesses.\nDuring the program you will hear from experienced founders who will share stories from the trenches on how they started and seeded their business, what they experienced during growth and how they took their company public or exited. We will also hear how investors recognize and decide on when and what to invest in, and who they want to engage with as partners.\nThe Life Sciences Collaborative would like for you to engage and learn from this year’s event about the challenges and successes of others, while networking with fellow life science colleagues. Whether your life science cycle is set, or you need to redefine how you prepare your business for the future, this event’s objective is for you to learn, share and develop relationships with others within this ever-evolving life sciences landscape.\nWe look forward to you joining this esteemed group of speakers in what proves to be a great event for learning, engaging and networking.\nIndividual Presenters\nChris Cashman\nChairman, MBF Therapeutics\nLouis P. Kassa III, MBA\nExecutive VP & COO, Pennsylvania Biotechnology Center of Bucks Co, Baruch S. Blumberg Institute & Hepititis B Foundation\nAdam Lohr\nPartner & Senior Analyst, RSM US LLP\nJ. David Owens\nBiopharmaceutical Executive, Entrpreneur, Angel Investor, Board Member\nLicensing Panel\nIhor Terleckyj (Moderator)\nCEO, CuRAGE Therapeutics\nAhmet Hamdi Cavusoglu, Ph.D.\nDirector, Academnic Venture Exchange\nMichael Poisel\nExecutive Director, PCI Ventures\nSteve Nappi\nAssociate VP of Technology Commercialization & Business Development, Temple University\nPaul Jeffrey\nPartner, BusStim, Virtual Biotech Accelerator\nPricing Panel\nAmy Williams (Moderator)\nPresident and Managing Partner, SageWorks Rx LLC\nShekhar Yerramilli\nFounder & CEO, The Guiding Start\nJoshua Parks\nFounder, Chiral Logic\nDr. Maria Lopes\nFormer Chief Medical Officer, MagellanRx\nMaximilian Vargas, PhD, MBA\nSenior Director, US Access Strategy and Account Management, Certara\nFunding Panel\nDennis Steadman (Moderator)\nPresident, Steadman Consulting, LLC & Steadman Capital, LLC\nAnthony P. Green, PhD\nVice President, Science and Technology, Ben Franklin Technology Partners of Southern Pennsylvania\nDaron Evans\nManaging Director, PoC Capital\nSusan Dillon, PhD\nCo-Founder, President and CEO, Aro Biotherapeutics Company\nAndrew Olsen\nPrincipal, Boathouse Capital\nExits Panel\nRyan Udell (Moderator)\nPartner, Corporate and Securities Group, White and Williams\nAdele Oliva\nFounding Partner, 1315 Capital\nJohn Gregg\nCEO, BalinBac Therapeutics\nMatt Steere\nManaging Director, Canaccord Financial\nRobert P. Ryan, PhD, D.A.B.T.\nPresident & CEO, Innova Therapeutics, Inc.\n
URL:https://lifesciencescollaborative.org/events/innovators-and-investors-the-journey-from-entry-to-exit/
ORGANIZER;CN=Amy Williams:MAILTO:
CATEGORIES:Princeton NJ - BG - EVENTS
LOCATION:Astra Zeneca Auditorium
ATTACH;FMTTYPE=image/jpeg:https://lifesciencescollaborative.org/wp-content/uploads/2024/09/IMG_4902_WEB.jpg
END:VEVENT
END:VCALENDAR